Cargando…

Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil

BACKGROUND: The implementation of antiretroviral (ARV) therapy caused a significant decrease in HIV-associated mortality worldwide. Nevertheless, mortality is still high among people living with HIV/AIDS and tuberculosis (TB). ARV-naïve HIV patients coinfected with tuberculosis (TB) have more option...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demitto, Fernanda O., Schmaltz, Carolina A. S., Sant’Anna, Flávia M., Arriaga, María B., Andrade, Bruno B., Rolla, Valeria C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553696/ https://www.ncbi.nlm.nih.gov/pubmed/31170171 http://dx.doi.org/10.1371/journal.pone.0217014

Ejemplares similares

Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV
por: Demitto, Fernanda O., et al.
Publicado: (2020)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
por: Schmaltz, Carolina Arana Stanis, et al.
Publicado: (2019)

Cutaneous tuberculosis and HIV infection at a referral centre in Rio de Janeiro, Brazil
por: Mann, Danielle, et al.
Publicado: (2018)

Impact of adverse drug reactions on the outcomes of tuberculosis treatment
por: Sant´Anna, Flávia M., et al.
Publicado: (2023)

Changes in the NK Cell Repertoire Related to Initiation of TB Treatment and Onset of Immune Reconstitution Inflammatory Syndrome in TB/HIV Co-infected Patients in Rio de Janeiro, Brazil—ANRS 12274
por: Giacoia-Gripp, Carmem Beatriz Wagner, et al.
Publicado: (2019)

Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients
por: da Silva, Tatiana Pereira, et al.
Publicado: (2017)

Tuberculosis Treatment Outcomes and Factors Associated with Each of Them in a Cohort Followed Up between 2010 and 2014
por: Cardoso, Mayara A., et al.
Publicado: (2017)

Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial
por: Xavier, Mariana S., et al.
Publicado: (2018)

T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens
por: da Silva, Tatiana P., et al.
Publicado: (2013)

Correction: Anemia in tuberculosis cases: A biomarker of severity?
por: de Mendonça, Edson Beyker, et al.
Publicado: (2021)

Anemia in tuberculosis cases: A biomarker of severity?
por: de Mendonça, Edson Beyker, et al.
Publicado: (2021)

Factors Impacting Early Mortality in Tuberculosis/HIV Patients: Differences between Subjects Naïve to and Previously Started on HAART
por: Schmaltz, Carolina Arana Stanis, et al.
Publicado: (2012)

Tuberculosis treatment outcomes of diabetic and non-diabetic TB/HIV co-infected patients: A nationwide observational study in Brazil
por: Villalva-Serra, Klauss, et al.
Publicado: (2022)

TB testing in HIV-positive patients prior to antiretroviral treatment
por: Spooner, E., et al.
Publicado: (2022)

Timing of Antiretroviral Therapy for HIV in the Setting of TB Treatment
por: Piggott, Damani A., et al.
Publicado: (2011)

Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV
por: Tabarsi, Payam, et al.
Publicado: (2009)

2300 Association between source case cavitation on chest radiograph and QuantiFERON-TB Gold In-Tube conversion among close contacts of active tuberculosis cases in Brazil
por: Saag, Lauren A., et al.
Publicado: (2018)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria
por: Odume, B., et al.
Publicado: (2017)

Antiretroviral Therapy in Prevention of HIV and TB: Update on Current Research Efforts
por: Granich, Reuben, et al.
Publicado: (2011)

Antiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis
por: Yan, Isabel, et al.
Publicado: (2016)

Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand
por: Gatechompol, Sivaporn, et al.
Publicado: (2019)

Factors associated with mortality in HIV patients failing antiretroviral therapy, in Salvador, Brazil
por: Haguihara, Tatiana, et al.
Publicado: (2019)

Is it time for Brazil to prioritize TB preventive therapy for all people living with HIV?
por: Maciel, Ethel L., et al.
Publicado: (2017)

Reply to “At the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection”
por: Saraceni, Valeria, et al.
Publicado: (2014)

HIV-TB coinfection: Clinico-epidemiological determinants at an antiretroviral therapy center in Southern India
por: Kamath, Ramachandra, et al.
Publicado: (2013)

Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV
por: Vinhaes, Caian L., et al.
Publicado: (2021)

Dysphonia and throat clearing in singers during the Covid-19 pandemic in Brazil
por: Sant'anna, Sabryna Farneze Nunes, et al.
Publicado: (2023)

The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis
por: Dodd, P J, et al.
Publicado: (2017)

Prevalence and Clinical Profiling of Dysglycemia and HIV Infection in Persons With Pulmonary Tuberculosis in Brazil
por: Arriaga, María B., et al.
Publicado: (2022)

Do common mental disorders decline over time in TB/HIV co-infected and HIV patients without TB who are on antiretroviral treatment?
por: Deribew, Amare, et al.
Publicado: (2013)

Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIV
por: Queiroz, Artur T. L., et al.
Publicado: (2022)

Trends and Predictors of Mortality Among HIV Positive Patients in the Era of Highly Active Antiretroviral Therapy in Uganda
por: Rubaihayo, John, et al.
Publicado: (2015)

Survival and predictors of mortality among HIV-positive children on antiretroviral therapy in public hospitals
por: Biyazin, Yalemgeta, et al.
Publicado: (2022)

Use of amplified Mycobacterium tuberculosis direct test in respiratory samples from HIV-infected patients in Brazil
por: Barreto, Leonardo Bruno Paz Ferreira, et al.
Publicado: (2014)

Clinical and genetic markers associated with tuberculosis, HIV-1 infection, and TB/HIV-immune reconstitution inflammatory syndrome outcomes
por: de Sá, Nathalia Beatriz Ramos, et al.
Publicado: (2020)

Trends and predictors of non‐communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil
por: Castilho, Jessica L, et al.
Publicado: (2019)

TB and HIV: how can we reduce mortality?
por: Lawn, S
Publicado: (2012)

Asymptomatic Leishmania infection in HIV-positive outpatients on antiretroviral therapy in Pernambuco, Brazil
por: Guedes, Diego Lins, et al.
Publicado: (2021)

Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania
por: Johannessen, Asgeir, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rnmigk09ctn3nl957949iljnoc